The most commonly used diabetes drug, Pioglitazone has been reported to increase the risk of bladder cancer by 63 percent. Though there are various other anti-diabetic drugs, Pioglitazone has gained much popularity due to its low cost.
Millions of diabetics around the world are prescribed with this drug since 2000. Though there have been repeated studies on its safety and efficacy, different studies have reported contradictory findings.
Rs.7 Diabetes Drug Boosts the Cost-Effectiveness of Pharma Market in India
Zydus Cadila has launched its new anti-diabetic drug, Tenglyn, a generic oral version of gliptins at the most affordable price of Rs. 7 per tablet in India.
Advertisement
‘Popularly used diabetes drug ‘pioglitazone’ can increase the risk of bladder cancer in diabetics by 63%.’
Tweet it Now
But a new study published in the British Medical Journal (BMJ) has found that this drug had a significant effect on the health of diabetics by increasing their risk of developing bladder cancer.
Researchers from the McGill University in Montreal analyzed 145,806 patients newly treated with diabetes drugs between 2000 and 2013 using data from the UK Clinical Practice Research Database. Of the patients, 622 were diagnosed with bladder cancer.
![Diabetes Drug Pioglitazone may Prevent Recurring Strokes]( "Diabetes Drug Pioglitazone may Prevent Recurring Strokes")
Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance.
They found that compared to other anti-diabetic drugs, Pioglitazone was the only drug that increased bladder cancer by 63%. Another diabetic drug, rosiglitazone which was withdrawn from use in 2010 due to an increased risk of cardiovascular disorders, including heart attack and heart failure did not increase the possibility of bladder cancer.
The team wrote, "In this large study, with up to 14.5 years of follow-up, pioglitazone was associated with an overall 63 percent increased the risk of incident bladder cancer."
Source: Medindia
Diabetes Drug Pioglitazone may Prevent Recurring Strokes
Pioglitazone, a drug used for type 2 diabetes, may prevent recurrent stroke and heart attacks in people with insulin resistance.
Advertisement
They found that compared to other anti-diabetic drugs, Pioglitazone was the only drug that increased bladder cancer by 63%. Another diabetic drug, rosiglitazone which was withdrawn from use in 2010 due to an increased risk of cardiovascular disorders, including heart attack and heart failure did not increase the possibility of bladder cancer.
The team wrote, "In this large study, with up to 14.5 years of follow-up, pioglitazone was associated with an overall 63 percent increased the risk of incident bladder cancer."
Source: Medindia
Government to Lift Ban on Anti-Diabetes Drug Pioglitazone
The central government has announced that it will be revoking the ban placed on the sale of anti-diabetes drug Pioglitazone.
Advertisement
 Drug for Diabetes PreventionActos (pioglitazone)a pill that is used to treat adult onset diabetes, is also found to prevent the development of Type 2 diabetes in high-risk people. | Advertisement
|
Advertisement
Recommended Reading
Latest Diabetes News
Researchers have shown that gestational diabetes can be identified as early as the first trimester of pregnancy, which is typically months before it is typically diagnosed.
A new smartphone app or support tool developed helps improve mental health in individuals with type 1 diabetes.
Type 2 diabetes mice injected with beta cells with increased CD63 protein marker production had their blood sugar levels restored to normal.
Good news to children with diabetes: New artificial pancreas can help improve blood sugar control in kids.
New study reveals the link between pre-sleep light exposure and gestational diabetes mellitus in pregnant women.